Sisyphus Speaks 313: Federal court won't hear homeopathic drug suit, citing FDA's "extensive regulatory scheme"

Summary: The FDA is now revisiting it's neglect of duty, a subject we've discussed several times over on SBM (also here and here). It held a two-day hearing and requested public comments on the subject. SFSBM submitted comments to the FDA, one among over 8,000 the FDA received.